Adamis Pharmaceuticals Corporation(ADMP) - 2023 Q2 - Quarterly Report
Adamis Pharmaceuticals CorporationAdamis Pharmaceuticals Corporation(US:ADMP)2023-08-19 00:42

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36242 ADAMIS PHARMACEUTICALS CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...